- Filed
- Feb 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Feb 10, 2026 | 79.7M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 78.79M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 76.73M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 68.88M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 68.59M sh |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | −$16.47M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | −$14.43M |
| Long Term Debt | Q3 2026 · Dec 31, 2025 | $4.85M |
| Long Term Debt | Q3 2026 · Sep 30, 2025 | $4.85M |
| Long Term Debt | Q3 2026 · Mar 31, 2025 | $139.78K |
| Short Term Debt | Q3 2026 · Dec 31, 2025 | $18.55M |
| Short Term Debt | Q3 2026 · Mar 31, 2025 | $19.87M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $5.14M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $4.84M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2024 | $5.81M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | −$26.6M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | −$28.02M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | −$28.08M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | −$25.07M |
| Stockholders Equity restated | Q3 2026 · Dec 31, 2024 | −$29.22M |
| Stockholders Equity restated | Q3 2026 · Sep 30, 2024 | −$33.09M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | −$32.53M |
| Stockholders Equity | Q3 2026 · Mar 31, 2024 | −$10.07M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $63.2M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $56.94M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $68.95M |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $58.27M |
| Current Assets | Q3 2026 · Dec 31, 2025 | $34.16M |
| Current Assets | Q3 2026 · Mar 31, 2025 | $26.95M |
| Total Assets | Q3 2026 · Dec 31, 2025 | $44.87M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $32.58M |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$0.12 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$0.20 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | −$0.04 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | −$1.06 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$0.12 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$0.20 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | −$0.04 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | −$1.06 |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $3.52M |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $9.91M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $2.77M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $49.03M |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $293.96K |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $524.02K |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $249.64K |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $3.54M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$9.15M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$15.26M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$2.11M |
| Net Income | Q3 2026 · Jun 30, 2025 | −$4.01M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$2.52M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$72.73M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$21.81M |
| Net Income | Q3 2026 · Jun 30, 2024 | −$48.41M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$2.36M |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$8.22M |
| Operating Income | Q3 2026 · Dec 31, 2024 | −$3.17M |
| Operating Income | Q3 2026 · Dec 31, 2024 | −$57.1M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $5.21M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $15.74M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $4.28M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $14.92M |
| Revenue | Q3 2026 · Dec 31, 2025 | $14.36M |
| Revenue | Q3 2026 · Dec 31, 2025 | $38.9M |
| Revenue | Q3 2026 · Dec 31, 2024 | $12.09M |
| Revenue | Q3 2026 · Dec 31, 2024 | $32.89M |